Find the Perfect Plan for Your Investment Journey
G
Latest price
52 Week Range
HK$35.00 - HK$80.80
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | HK$76.93B |
EV | HK$70.69B |
Shares Outstanding | 1.03B |
Beta | 0.79 |
Analyst Rating | BUY |
Analyst Target Price | HK$81.94 |
P/E 2025E | 29.09x |
P/Revenue 2025E | 10.35x |
Revenue | 52.80% |
EPS | 38.70% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 26.00% |
EPS | 22.30% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 81.74% |
Net Profit Margin 2025E | 35.66% |
ROE 2025E | 32.23% |
ROCE 2024 | 35.96% |
DPS 2025E | HK$1.26 |
Payout Ratio 2025E | 47.02% |
Div. Yield 2025E | 1.61% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Giant Biogene Holding Co., Ltd.
2367
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Yan, Jianya
Employees
1,758
Website
www.xajuzi.comIPO Date
2022-11-04
Headquarters
No. 1855, Shanglin Yuan, 7th Road, Chang’an District, Xi’an, Shaanxi Province China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved